Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $410 at Morgan Stanley

February 7, 2020 5:31 AM
Morgan Stanley analyst Matthew Harrison ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles